- B2B
- Early StageStartup in initial stages
- Website
- Location
- Company size
- 11-50 people
- Total raised
- $11.7M
- Company type
- Medical Device
- Market
Capillary Biomedical careers
The Problem: insulin pumps improve blood glucose outcomes and quality of life for diabetic patients. But only 30% of people with Type 1 Diabetes wear an insulin pump, and only a tiny fraction of people with Type 2 wear one. Users have said they’re unreliable, uncomfortable, difficult to use and cause stress for the wearer.
Our Solution: the SteadiSet infusion set with SteadiFlow cannula technology is designed to take the stress out of infusion sets by reducing failures, minimizing pain, simplifying use and improving the predictability of insulin delivery.
Our Solution: the SteadiSet infusion set with SteadiFlow cannula technology is designed to take the stress out of infusion sets by reducing failures, minimizing pain, simplifying use and improving the predictability of insulin delivery.
Capillary Biomedical hasn't added any jobs yet
Get notified when Capillary Biomedical posts new jobs.
Jeffrey Joseph
Vice-Chairman & Director of Research@Thomas Jefferson University; Co-founded Capillary Biomedical, Animas (JNJ acquired), Jefferson Artificial Pancreas Center
Paul Strasma
Medical device CEO @Capillary Biomedical (Cove Fund, TCA, NYA); VP Marketing & Clinicals @GluMetrics; Abbott Diabetes Care, Baxter BioScience; MBA @MIT Sloan
Total raised
$11.7M
Funded over
4 rounds
Latest round
Seed (Aug 2020)
The Marketing Arm • Houston • 2 weeks ago
Glooko • Remote • 3 weeks ago
Trace3 • Grand Rapids • 4 weeks ago
Twitch • San Francisco • 4 weeks ago
Houzz • Nepal • 4 weeks ago